Pershing Square Holdings Falls 25.6% Year-to-Date on Valeant
This article is for subscribers only.
Pershing Square Holdings Ltd., the publicly traded security of Bill Ackman’s activist hedge fund, lost 25.6 percent this year through March 31, extending losses primarily due to its stake in embattled drugmaker Valeant Pharmaceuticals International Inc.
Pershing Square posted updated performance data on its website Friday. The portfolio mirrors the investments of Ackman’s hedge fund, Pershing Square Capital Management.